We apply our expertise in science and innovation to
society’s biggest health challenges. Responsibility is a core
part of our business strategy
Technology Platforms
Pharmadax is committed to develop modified release generics in various therapeutic segments. The team brings a good mix of innovation and timely execution to ensure efficient dossier filing.
We have platforms of high precision modified release solid oral dosage forms, which can be utilised for wide gamut molecules. Our scientists ensure that the cutting edge technology continues to be dynamic to be able to use variety of bioequivalent products to market.
Non-Erosive Adjustable Drug Delivery System
Non-Erosive Adjustable Drug Delivery System (NEADDS) is an advanced drug delivery system developed by Pharmadax, it uses non-erosive polymers and water soluble excipients to customize drug release rate by adjusting composition resulting in to a dynamic formulation with specified release profile.
MR-ODT: Modified-Release Orally Disintegrating Tablet
Product quickly disintegrates in the mouth and does not need to be swallowed using water. This way it increases patient compliance. MR-ODT is a new generation dosage form offered marked benefit to molecules to be delivered for quick action in buccal cavity or in gastro intestinal tract.
Sustained Release Gastro-Retentive Dosage Form
Gastro-retentive dosage form is a leading methodology in the field of site-specific orally administered modified release system, it improves drug absorption, provides local action and minimizes mucosal irritation.
Transdermal Patches
Transdermal patches comprise a method of delivering medication through the skin in a non-invasive manner.
It offers several benefits over traditional delivery methods, such as bypassing the liver’s metabolic activity and medication is supplied gradually and constantly.
